"All kinds of enhancements" have crept into claims from providers, Ronanki said, and health plans have responded. But his company is impartial about the net value and strives to make the claim accurate in the first place, he said.
In the third segment from an interview with Managed Healthcare Executive, Lyric CEO Rajeev Ronanki, M.S., discusses revenue cycle management (RCM) and "disarming both sides to where RCM goes back to its roots of making sure that the billing for whatever services are rendered is accurate."
Ronanki said that provider RCM started out with the intent of making sure billing was accurate but "all kinds of enhancements have crept in." Health plans responded with efforts to detect and weed out claims that were too high. "It's a zero-sum game where neither party wins in the process," he said.
Lyric's customers are health plans. But the company is focused on accuracy, Ronanki said. In some cases, that might mean determining that a provider deserves a higher payment than what was billed for. In others, Lyric might find that the provider has "additional charges that don't seem to fit the pattern of what this claim should look like," he said.
"Our core philosophy is that we're impartial to the net value of what we're rendering judgment on," and to make sure the claim is accurate, Ronanki said.
FDA Accepts NDA for Zoliflodacin, Potentially First Gonorrhea Antibiotic in Decades
The FDA has accepted a New Drug Application for zoliflodacin, a first-in-class oral antibiotic for treating uncomplicated gonorrhea, offering a potential new option amid rising antibiotic resistance.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Amanda M. Shafton, DNP, CNM, FACNM | 2025 MHE Emerging Leaders in Healthcare
National director of midwifery, Ob Hospitalist Group. Ob Hospitalist Group (OBHG) provides hospitals with obstetric services.
Read More
Conversations With Perry and Friends
Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
FDA Approves Ibtrozi For Adults With ROS1+ NSCLC
Ibtrozi had a 90% response rate in treatment naïve adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer, according to the results of a news release.
Read More
Cigna Launches AI Tools to Simplify Health Insurance, Improve Customer Experience
These tools, available through the myCigna member portal, are designed to make navigating health insurance more straightforward and to improve overall customer experience, according to a news release sharing the announcement today.
Read More
FDA Accepts NDA for Zoliflodacin, Potentially First Gonorrhea Antibiotic in Decades
The FDA has accepted a New Drug Application for zoliflodacin, a first-in-class oral antibiotic for treating uncomplicated gonorrhea, offering a potential new option amid rising antibiotic resistance.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Amanda M. Shafton, DNP, CNM, FACNM | 2025 MHE Emerging Leaders in Healthcare
National director of midwifery, Ob Hospitalist Group. Ob Hospitalist Group (OBHG) provides hospitals with obstetric services.
Read More
Conversations With Perry and Friends
Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
FDA Approves Ibtrozi For Adults With ROS1+ NSCLC
Ibtrozi had a 90% response rate in treatment naïve adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer, according to the results of a news release.
Read More
Cigna Launches AI Tools to Simplify Health Insurance, Improve Customer Experience
These tools, available through the myCigna member portal, are designed to make navigating health insurance more straightforward and to improve overall customer experience, according to a news release sharing the announcement today.
Read More
2 Commerce Drive
Cranbury, NJ 08512
609-716-7777
